Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

24432 ARTÍCULOS , VIENDO DEL 20326 AL 20340

Impact of TRPV1 on Pathogenesis and Therapy of Neurodegenerative Diseases

Wang W, Sun T.

Molecules. 2023 Dec 28;29(1):181. doi: 10.3390/molecules29010181.

The contribution of the peripheral immune system to neurodegeneration

Berriat F, Lobsiger CS, Boillée S.

Nat Neurosci. 2023 Jun;26(6):942-954. doi: 10.1038/s41593-023-01323-6. Epub 2023 May 25.

Glial Glutamate Transporter-Mediated Plasticity: System x(c)(-)/xCT/SLC7A11 and EAAT1/2 in Brain Diseases

Dahlmanns M, Dahlmanns JK, Savaskan N, Steiner HH, Yakubov E.

Front Biosci (Landmark Ed). 2023 Mar 20;28(3):57. doi: 10.31083/j.fbl2803057.

Targeting the central nervous system: From synthetic nanoparticles to extracellular vesicles-Focus on Alzheimer's and Parkinson's disease

Hernando S, Santos-Vizcaíno E, Igartua M, Hernandez RM.

Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2023 Sep-Oct;15(5):e1898. doi: 10.1002/wnan.1898. Epub 2023 May 8.

Traversing through the cell signaling pathways of neuroprotection by betanin: therapeutic relevance to Alzheimer's Disease and Parkinson's Disease

Phukan BC, Roy R, Paul R, Mazumder MK, Nath J, Bhattacharya P, Borah A.

Metab Brain Dis. 2023 Mar;38(3):805-817. doi: 10.1007/s11011-023-01177-8. Epub 2023 Feb 6.

Brain iron acquisition: An overview of homeostatic regulation and disease dysregulation

Baringer SL, Simpson IA, Connor JR.

J Neurochem. 2023 Jun;165(5):625-642. doi: 10.1111/jnc.15819. Epub 2023 Apr 12.

Pharmacological and Pathological Relevance of S100 Proteins in Neurological Disorders

Goswami D, Anuradha U, Angati A, Kumari N, Singh RK.

CNS Neurol Disord Drug Targets. 2023;22(10):1403-1416. doi: 10.2174/1871527322666221128160653.

[The exposome in the context of preventive measures for Alzheimer's and Parkinson's diseases]

Schäffer E, Piel J.

Nervenarzt. 2023 Oct;94(10):892-903. doi: 10.1007/s00115-023-01538-9. Epub 2023 Aug 28.

Molecular Regulation of the CNS by Vitamin D

Máčová L, Kancheva R, Bičíková M.

Physiol Res. 2023 Dec 17;72(S4):S339-S356. doi: 10.33549/physiolres.935248.

Anti-amyloid potential of some phytochemicals against Aβ-peptide and α-synuclein, tau, prion, and Huntingtin protein

Jerom JP, Madhukumar S, Nair RH, Narayanan SP.

Drug Discov Today. 2023 Dec;28(12):103802. doi: 10.1016/j.drudis.2023.103802. Epub 2023 Oct 17.

An update on the role of Hippo signaling pathway in ischemia-associated central nervous system diseases

Wei X, Huang G, Liu J, Ge J, Zhang W, Mei Z.

Biomed Pharmacother. 2023 Jun;162:114619. doi: 10.1016/j.biopha.2023.114619. Epub 2023 Mar 31.

Molecular insights into the pathogenic impact of vitamin D deficiency in neurological disorders

Anwar MJ, Alenezi SK, Alhowail AH.

Biomed Pharmacother. 2023 Jun;162:114718. doi: 10.1016/j.biopha.2023.114718. Epub 2023 Apr 20.

[Relationships between microbiome and neurodegeneration]

Bang C, Heinzel S.

Nervenarzt. 2023 Oct;94(10):885-891. doi: 10.1007/s00115-023-01537-w. Epub 2023 Sep 6.

From Recognition to Remedy: The Significance of Biomarkers in Neurodegenerative Disease Pathology

Toader C, Dobrin N, Brehar FM, Popa C, Covache-Busuioc RA, Glavan LA, Costin HP, Bratu BG, Corlatescu AD, Popa AA, Ciurea AV.

Int J Mol Sci. 2023 Nov 9;24(22):16119. doi: 10.3390/ijms242216119.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias